Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Rheumatology · Neuropsychiatric Systemic Lupus Erythematosus

What Causes Lupus Brain Fog & How Is It Managed?

At a Glance

Lupus brain fog is a recognized cognitive symptom caused by inflammation, autoantibodies, and blood vessel changes in the brain. Management involves adjusting medications, treating underlying lupus activity, and using cognitive pacing strategies to improve memory and daily functioning.

Many people with systemic lupus erythematosus (SLE) experience periods where thinking clearly, remembering details, or finding the right words feels incredibly difficult. This is commonly referred to as “lupus fog,” though medically it is known as cognitive dysfunction, a manifestation of Neuropsychiatric SLE (NPSLE). If you are experiencing this, you are not alone—it is a real, recognized symptom of your disease.

How to Explain Lupus Fog to Your Doctor

Because cognitive symptoms are invisible, it can be terrifying to bring them up to a doctor for fear of being dismissed. The most helpful thing you can do is give specific, concrete examples of how your thinking has changed. Keep a symptom log to track what time of day your foggy moments happen, whether they coincide with physical lupus flares, and what specific challenges you face.

Instead of just saying, “I have brain fog,” try sharing examples like:

  • “I lose my train of thought mid-sentence and cannot get it back.”
  • “I get lost or confused on routes I drive every day.”
  • “I struggle to find common words, like ‘refrigerator’ or ‘keys.’”
  • “I can’t follow the plot of a TV show or a conversation with multiple people.”

What Causes Lupus Fog?

Lupus brain fog is complex and is usually caused by a combination of factors related to how lupus affects the body and the central nervous system. You don’t need to memorize these medical terms, but understanding the biology can help you feel more in control.

  • Autoantibodies: In lupus, the immune system creates autoantibodies that mistakenly attack the body’s own tissues. Certain autoantibodies, such as anti-ribosomal P, have been linked to neuropsychiatric symptoms and can interfere with how brain cells function [1][2].
  • Antiphospholipid Antibodies (aPL): These are a specific type of autoantibody that increase the risk of blood clots. In some SLE patients, aPL can cause microscopic clots or changes in blood flow to the brain, directly contributing to cognitive dysfunction [3][4].
  • Inflammation in the Brain: Lupus can cause systemic inflammation that reaches the brain. Elevated levels of inflammatory proteins, such as interleukin-6 (IL-6), in the central nervous system are associated with learning and memory difficulties [5][6].
  • Blood Vessel Changes: Lupus can lead to inflammatory changes in the tiny blood vessels of the brain (vasculopathy) and alter the blood-brain barrier—the protective layer that keeps harmful substances out of the brain [7]. This altered barrier can allow inflammatory cells to enter, leading to changes in brain networks and grey matter [8][9].
  • Medication Side Effects: Some medications commonly prescribed for lupus-related issues (such as gabapentin for nerve pain, certain antidepressants, or even corticosteroids) can cause side effects that mimic or worsen brain fog.

Note: Your doctor may order blood tests or an MRI to look for these causes. However, it is important to know that standard tests can sometimes come back normal even when your lupus fog is severe. Your symptoms are still real, and an “all-clear” test just means they have ruled out certain specific causes.

How is it Evaluated and Managed?

Managing lupus fog requires an individualized, team-based approach, often involving a rheumatologist, neurologist, and sometimes a psychologist or occupational therapist [10]. Because cognitive dysfunction in SLE is dynamic and can fluctuate over time [11], management is ongoing.

1. Medical Evaluation and Medication Adjustments
First, your doctor will evaluate your cognitive symptoms. This may involve formal neuropsychological testing to pinpoint exactly which areas of thinking are affected, or an MRI to check for changes in your brain’s blood vessels or grey matter [9]. They will also review your medication list to see if any prescriptions are contributing to the fog.

Once a baseline is established, medical management focuses on treating the underlying lupus:

  • Antimalarials: Medications like hydroxychloroquine are cornerstone therapies for SLE that help control overall disease activity and protect the body [12].
  • Anticoagulants: If your cognitive dysfunction is driven by antiphospholipid antibodies, your doctor may recommend blood thinners to improve blood flow and prevent microscopic clots [13][14].
  • Immunosuppressants and Corticosteroids: Standard, daily brain fog does not usually require heavy immunosuppression. However, if your cognitive symptoms are caused by severe, acute inflammation in the brain, doctors may prescribe high-dose glucocorticoids (steroids) or immunosuppressants like mycophenolate mofetil or cyclophosphamide [15][16].

2. Treating Contributing Factors
Brain fog is heavily influenced by other aspects of living with lupus. Depression, anxiety, sleep disturbances, and chronic pain all correlate strongly with cognitive impairment [9]. Physical exercise and psychological interventions have been shown to improve fatigue, depression, and pain in SLE patients [17], which in turn can significantly lift the mental fog.

3. Cognitive Pacing and Rehabilitation
Adapting your daily routine can make a profound difference:

  • Pacing: Break complex tasks into smaller steps and take frequent mental breaks to avoid cognitive fatigue.
  • Cognitive Remediation: Formal cognitive training and rehabilitation programs can help improve executive function (the mental skills that include planning, organizing, multitasking, and focusing), working memory, and learning [18][19]. This often involves learning compensatory strategies, like relying on calendars, lists, and alarms to reduce the mental load [20].

Common questions in this guide

How do I explain lupus brain fog to my doctor?
Keep a detailed symptom log with specific examples of your cognitive struggles, such as losing your train of thought or forgetting common words. Note when these episodes occur and if they happen during physical lupus flares so your doctor can identify patterns.
What causes brain fog in lupus patients?
Lupus brain fog is typically caused by a combination of factors including systemic inflammation, autoantibodies that interfere with brain cells, and inflammatory changes in blood vessels. Side effects from certain medications can also mimic or worsen these cognitive issues.
Can antiphospholipid antibodies cause cognitive issues in lupus?
Yes, antiphospholipid antibodies can increase the risk of microscopic blood clots and alter blood flow to the brain. This can directly contribute to cognitive dysfunction in some patients with lupus.
How is lupus brain fog evaluated?
Your doctor may recommend formal neuropsychological testing to identify specific areas of cognitive decline. They might also order an MRI to check for changes in brain blood vessels or grey matter, alongside evaluating your current medication list.
Will standard medical tests always show a cause for my lupus fog?
Not always. Standard tests like blood work or an MRI can sometimes come back normal even when your cognitive symptoms are severe. A normal test simply means your doctor has ruled out certain specific causes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you think my brain fog is being driven by active lupus inflammation, antiphospholipid antibodies, or possibly a side effect of my current medications?
  2. 2.Should I undergo formal neuropsychological testing to pinpoint exactly which areas of my memory or thinking are most affected?
  3. 3.Would a referral to an occupational therapist or cognitive rehabilitation specialist be appropriate for me?
  4. 4.At what point should I consider my cognitive symptoms a medical emergency? What are the 'red flags' I should watch for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Anti-Ribosomal-P Antibody Association with Neuropsychiatric Lupus in Sudanese Patients Attending Rheumatology Clinic in Omdurman Military Hospital.

    Taha ZI, Awad Ibrahim IA, Hamza SB, et al.

    Open access rheumatology : research and reviews 2022; (14()):281-289 doi:10.2147/OARRR.S387650.

    PMID: 36440103
  2. 2

    Correlation between neuropsychiatric systemic lupus erythematosus and immunological markers: a real-world retrospective study.

    Jiang Y, Yuan F, Xu X, et al.

    Clinical rheumatology 2024; (43(9)):2833-2842 doi:10.1007/s10067-024-07056-6.

    PMID: 38997542
  3. 3

    Neurological Complications in Patients with Systemic Lupus Erythematosus.

    Shaban A, Leira EC

    Current neurology and neuroscience reports 2019; (19(12)):97 doi:10.1007/s11910-019-1012-1.

    PMID: 31773306
  4. 4

    Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome.

    Yang L, Guo R, Liu H, et al.

    Frontiers in immunology 2025; (16()):1527554 doi:10.3389/fimmu.2025.1527554.

    PMID: 40181965
  5. 5

    Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.

    Reynolds J, Huang M, Li Y, et al.

    Journal of neuroinflammation 2024; (21(1)):89 doi:10.1186/s12974-024-03085-9.

    PMID: 38600510
  6. 6

    Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.

    Liang R, Zheng L, Ji T, et al.

    Lupus 2022; (31(2)):187-193 doi:10.1177/09612033211069853.

    PMID: 35042378
  7. 7

    Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.

    Lecler A, Sadik JC, Savatovsky J

    AJNR. American journal of neuroradiology 2019; (40(8)):E41 doi:10.3174/ajnr.A6137.

    PMID: 31345948
  8. 8

    Abnormal brain functional networks in systemic lupus erythematosus: a graph theory, network-based statistic and machine learning study.

    Yang Y, Bai R, Liu S, et al.

    Brain communications 2025; (7(2)):fcaf130 doi:10.1093/braincomms/fcaf130.

    PMID: 40207059
  9. 9

    Assessing grey matter structural alterations in systemic lupus erythematosus using synthetic MRI.

    Deng K, Wu C, Qin Y, et al.

    Lupus science & medicine 2025; (12(2)) doi:10.1136/lupus-2025-001505.

    PMID: 40659388
  10. 10

    Psychiatric manifestations of systemic lupus erythematosus: A brief review with two case-reports.

    Kassim FM, Wordefo DK, Berhanu M, et al.

    SAGE open medical case reports 2024; (12()):2050313X241229010 doi:10.1177/2050313X241229010.

    PMID: 38313038
  11. 11

    Cognitive dysfunction in systemic lupus erythematosus: Insights from a two-year longitudinal study in a Brazilian cohort.

    Scoto Dias E, Tercziany Vanzin JH, Augusto Borba E, et al.

    Reumatologia clinica 2025; (21(7)):501941 doi:10.1016/j.reumae.2025.501941.

    PMID: 40921514
  12. 12

    GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane-induced lupus mouse model.

    Toumi E, Bestion E, Militello M, et al.

    British journal of pharmacology 2025; (182(16)):3786-3799 doi:10.1111/bph.70058.

    PMID: 40258389
  13. 13

    Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers.

    Hassan F, Naffaa ME, Saab A, Putterman C

    Brain sciences 2022; (12(2)) doi:10.3390/brainsci12020222.

    PMID: 35203985
  14. 14

    Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female.

    Jamal F, Kumar R, Hakobyan N

    Cureus 2024; (16(7)):e64856 doi:10.7759/cureus.64856.

    PMID: 39156266
  15. 15

    Serotonin Syndrome-Mimicking Manifestations in a Patient with Systemic Lupus Erythematosus.

    Chen SC, Huang YS, Wu CS

    Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123516.

    PMID: 38930045
  16. 16

    Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy.

    Fujita Y, Fukui S, Ishida M, et al.

    Internal medicine (Tokyo, Japan) 2018; (57(20)):3025-3028 doi:10.2169/internalmedicine.0934-18.

    PMID: 29780145
  17. 17

    Non-pharmacologic therapies for systemic lupus erythematosus.

    Fangtham M, Kasturi S, Bannuru RR, et al.

    Lupus 2019; (28(6)):703-712 doi:10.1177/0961203319841435.

    PMID: 30961418
  18. 18

    Effects of non-pharmacological interventions on cancer-related cognitive impairment in patients with breast cancer: A systematic review and network meta-analysis.

    Yang P, Hu Q, Zhang L, et al.

    European journal of oncology nursing : the official journal of European Oncology Nursing Society 2025; (75()):102804 doi:10.1016/j.ejon.2025.102804.

    PMID: 39919600
  19. 19

    Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

    Vita A, Barlati S, Ceraso A, et al.

    The American journal of psychiatry 2024; (181(6)):520-531 doi:10.1176/appi.ajp.20230396.

    PMID: 38476043
  20. 20

    An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis.

    De Meo E, Portaccio E, Bonacchi R, et al.

    Expert review of neurotherapeutics 2025; (25(2)):227-243 doi:10.1080/14737175.2025.2450788.

    PMID: 39801437

This page provides educational information on lupus brain fog and its management. Always consult your rheumatologist or neurologist for medical advice and before making any changes to your treatment plan.

Get notified when new evidence is published on Systemic lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.